News

Blue Ribbon Income Fund Details Upcoming Monthly Dividends

Blue Ribbon Income Fund Details Upcoming Monthly Dividends

Understanding Blue Ribbon Income Fund's Distributions

Blue Ribbon Income Fund (TSX:RBN) has officially announced its distribution strategy for the upcoming months, providing exciting news for unitholders. The Fund intends to distribute $0.04 per unit monthly for record dates spanning from October through December. This consistent return reflects the Fund's commitment to delivering value to its investors.

Distribution Schedule

For those interested in the schedule, here is the upcoming distribution timeline:

1. **October 31, 2025** - Payment date on November 14, 2025
2. **November 28, 2025** - Payment date on December 12, 2025
3. **December 31, 2025** - Payment date on January 15, 2026

Long-Term Value of the Fund

Since its inception in September 1997, Blue Ribbon Income Fund has delivered impressive cash distributions totaling $22.17 per unit. This track record illustrates the Fund's focus on rewarding its unitholders over the long term.

Distribution Reinvestment Plan (DRIP)

Unitholders are encouraged to consider joining the Fund's Distribution Reinvestment Plan (DRIP). This program allows investors to reinvest their distributions without incurring any commissions, thereby taking advantage of the power of compound growth. Investors interested in the DRIP can easily enroll by connecting with their financial advisors.

Contact Information for Unitholders

For more detailed inquiries, unitholders can contact their financial advisors directly. Additionally, they can reach out to Brompton’s investor relations at 416-642-6000 (or toll-free at 1-866-642-6001) or email info@bromptongroup.com. Further details are also available on their website: www.blueribbonincomefund.com.

Important Considerations for Investors

As with any investment, buying or selling units on the Toronto Stock Exchange or alternative Canadian platforms may incur brokerage fees. It’s important for investors to recognize that units can trade for amounts above or below their net asset value. Furthermore, there are ongoing fees tied to owning units, underscoring the need to review all disclosure documents which contain vital information about the Fund. These documents can be accessed from public filings available online.

Frequently Asked Questions

What is the distribution amount for Blue Ribbon Income Fund?

The Fund is set to distribute $0.04 per unit monthly during the announced period.

How can I reinvest my distributions?

You can reinvest your distributions by joining the DRIP, which is available through your investment advisor.

When will the upcoming payments be made?

Payments are scheduled for November 14, December 12, and January 15 for the respective months.

How long has the Fund been operational?

Blue Ribbon Income Fund has been operating since September 1997.

Who should I contact for more information?

For more details, contact Brompton's investor relations or check their website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Bramshill Fund Takes Top Spot in 2026 Fund Awards

Updated Category News Views 68

Another Feather in Bramshill's Cap They've done it again, folks. The Bramshill Multi-Strategy Income Fund has just snagged the 40 Act Fund of the Year award at the 2026 Hedge Fund Performance Awards. This ain't just another plaque for the wall; it's a nod to some serious heavy lifting by the folks handling this beast of a portfolio. The award, dished out by With...

Continue Reading
Lean Focus Expands: Bridging Global Expertise in APAC

Updated Category News Views 67

A New Era for Lean Focus in the Asia Pacific The wave of business dynamics in APAC just got a little more intense. Lean Focus has thrown its hat in the ring, expanding into the Asia Pacific—a move that could shift how businesses operate in this bustling region. Forget the corporate hype for a moment and think about what this really means: local expertise, hands-on...

Continue Reading
Lyric Health & VivaScore: Revolutionizing Care Integration

Updated Category News Views 106

Partnering for a Healthier Tomorrow Blood, sweat, and tears—health's never been for the faint of heart. Now, Lyric Health and VivaScore are teaming up to give healthcare a serious upgrade. They're not just pushing papers—these folks mean business with their brand-new strategic partnership. The synergy between the brains at VivaScore and the ecosystem that Lyric's...

Continue Reading
Andersen 400 Series Patio Door Wins 2027 Award

Updated Category News Views 94

Andersen's Winning Streak Continues Ever got that feeling when you see an old player pulling off a brand-new trick in the game they love? That's kind of what Andersen Windows just pulled off with their 400 Series patio door snagging the 2027 Home Reno Award from Good Housekeeping. You could say Andersen's figured out how to keep the classics fresh without losing that...

Continue Reading
SEEKINK Dazzles with Game-Changing ePaper Innovations

Updated Category News Views 42

A New Dawn for ePaper Technology In the whirlwind of the Electronica 2026 expo in Munich, it wasn’t some Silicon Valley juggernaut, but SEEKINK and TOPTE making headlines with their cutting-edge ePaper innovations. These folks may be quiet players, but with hall fans stirred and tongues wagging at Hall B6 Booth 518, they're changing the game in sustainable display tech....

Continue Reading
Hexnode XDR Expands Threat Detection, MacOS Support

Updated Category News Views 78

Hexnode XDR: A Game Changer for MacOS Threats Ever heard of Hexnode? Well, today's chat is all about them beefing up their XDR platform. They’ve sagely added support for macOS—finally given the platform some love alongside Windows. It's about time! This move is a big win for everyone whose daily grind depends on keeping threats at bay across platforms. We’re talking...

Continue Reading
Accro's Vitiligo Trial Moves Fast with Fosun's Boost

Updated Category News Views 50

Launching into Vitiligo Treatment Trials I'll tell you, the biotech world isn't for the faint-hearted, especially when you're juggling hefty terms like 'TYK2/JAK1'. But here we are, watching Accro Bioscience and Fosun Pharma dive headlong into the vitiligo space with this Phase II/III trial of AC-201. They've bagged the IND clearance, and now the first patient is in the...

Continue Reading
Viatris Engages Investors at Key Healthcare Conferences

Updated Category News Views 22

Viatris Steps Into the Limelight Across Conferences Investors, listen up—Viatris Inc. is about to spill some beans at a trio of high-stakes healthcare gatherings. Set to rub elbows with the who's who of the biopharma world, this global healthcare crusader's on a mission. They're lining up to have face time at the UBS Global Biopharma Conference, the Jefferies Global...

Continue Reading
IASO Bio's In Vivo CAR-T: A Game Changer for Oncology?

Updated Category News Views 21

You ever feel like you're watching history happen right in front of you? That's the vibe with IASO Bio's latest move in the realm of oncology. This outfit just scored a major victory, getting China's NMPA and the U.S. FDA to greenlight their IASO208, a CD20-targeting in vivo CAR-T therapy. It's not every day you see a company land dual regulatory nods like...

Continue Reading
The DOG CATCHER: A New Spin on Pet Waste Cleanup

Updated Category News Views 43

Revolutionizing the Dreaded Pet Waste Duty Folks, here's a little dose of innovation from the streets of Baltimore: a gadget called the DOG CATCHER. No, it’s not about catching stray dogs, but dealing with their unpleasant leavings. This invention's got a patent pending and all, promising to make the nasty business of dog waste collection a whole lot less disgusting. I...

Continue Reading

Top 5 Most Recently Viewed Articles

Revature Secures Top Honors in HCM Excellence Awards 2025

Updated Category News Views 204

Revature Shines at the HCM Excellence Awards 2025 Revature, a leader in technology talent development, recently celebrated remarkable success at the HCM Excellence Awards 2025. With a relentless drive for excellence and innovation, the company earned two Gold awards and one Silver award for its outstanding contributions in Learning and Development. Categories and...

Continue Reading
BAB, Inc. Declares Cash Distribution for Shareholders

Updated Category News Views 114

BAB, Inc. Declares Quarterly Cash Distribution BAB, Inc. (OTCQB: BABB), headquartered in Deerfield, Illinois, recently announced an exciting update for its shareholders. The company’s Board of Directors has declared a quarterly cash distribution of one cent ($0.01) per share. This distribution is payable on a set date and represents a steadfast commitment to its...

Continue Reading
MasterBrand's Financial Report: Steady Progress in Q3 2024

Updated Category News Views 68

MasterBrand's Q3 2024 Financial Highlights MasterBrand, Inc. (NYSE: MBC) recently unveiled its financial results for the third quarter of 2024, demonstrating resilience despite various market challenges. As the largest residential cabinet manufacturer in North America, MasterBrand reported net sales of $718.1 million, reflecting a 6% increase compared to the previous...

Continue Reading
Nexalin Technology Teams Up with UCSD on Clinical Trial of Gen-3 Halo Headset

Updated Category News Views 92

Nexalin Technology and UCSD Collaborate on Innovative Clinical Trial Nexalin Technology, Inc. (NASDAQ: NXL; NXLIW) has exciting news to share as they embark on a groundbreaking clinical trial in collaboration with the University of California, San Diego. This trial, led by Dr. Ming Xiong Huang, aims to provide veterans with advanced treatment options for mild Traumatic...

Continue Reading
Boardwalk REIT Highlights Strong Performance and Growth Plans

Updated Category News Views 172

Boardwalk REIT Shares Insights on Leasing and Investments Boardwalk Real Estate Investment Trust (TSX: BEI.UN) provides detailed updates on its leasing performance and capital allocation strategies. In the typically slower winter months, the Trust has maintained its focus on high occupancy rates and enhancing Resident Member retention. As the new year approaches,...

Continue Reading